Luxturna – “Now Approved” Websites




Brand: Luxturna (voretigene neparvovec-rzyl), Injection
Parent Company: Spark Therapeutics
Drug Type: Prescription
Drug Category: Ophthalmology
Campaign: now-approved
Targeting: HCPs, Patients, Caregivers
Patient Website: https://luxturna.com/
HCP Website: https://luxturnahcp.com/